BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16407191)

  • 1. Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction.
    Horsefield R; Yankovskaya V; Sexton G; Whittingham W; Shiomi K; Omura S; Byrne B; Cecchini G; Iwata S
    J Biol Chem; 2006 Mar; 281(11):7309-16. PubMed ID: 16407191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quinone-binding site in succinate-ubiquinone reductase from Escherichia coli. Quinone-binding domain and amino acid residues involved in quinone binding.
    Yang X; Yu L; He D; Yu CA
    J Biol Chem; 1998 Nov; 273(48):31916-23. PubMed ID: 9822661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quinone-binding and catalytic site of complex II.
    Maklashina E; Cecchini G
    Biochim Biophys Acta; 2010 Dec; 1797(12):1877-82. PubMed ID: 20175986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of Escherichia coli succinate:quinone oxidoreductase with an occupied and empty quinone-binding site.
    Ruprecht J; Yankovskaya V; Maklashina E; Iwata S; Cecchini G
    J Biol Chem; 2009 Oct; 284(43):29836-46. PubMed ID: 19710024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of catalytic activity and inhibitors of quinone reactions of succinate dehydrogenase (Succinate-ubiquinone oxidoreductase) and fumarate reductase (Menaquinol-fumarate oxidoreductase) from Escherichia coli.
    Maklashina E; Cecchini G
    Arch Biochem Biophys; 1999 Sep; 369(2):223-32. PubMed ID: 10486141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors.
    Huang LS; Lümmen P; Berry EA
    Biochim Biophys Acta Proteins Proteom; 2021 Sep; 1869(9):140679. PubMed ID: 34089891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate: quinone oxidoreductases: new insights from X-ray crystal structures.
    Lancaster CR; Kröger A
    Biochim Biophys Acta; 2000 Aug; 1459(2-3):422-31. PubMed ID: 11004459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates.
    Siebels I; Dröse S
    Biochim Biophys Acta; 2013 Oct; 1827(10):1156-64. PubMed ID: 23800966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of substituents of the benzoquinone ring on electron-transfer activities of ubiquinone derivatives.
    Gu LQ; Yu L; Yu CA
    Biochim Biophys Acta; 1990 Feb; 1015(3):482-92. PubMed ID: 2154255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex II from a structural perspective.
    Horsefield R; Iwata S; Byrne B
    Curr Protein Pept Sci; 2004 Apr; 5(2):107-18. PubMed ID: 15078221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in proton donor/acceptor pathways in succinate:quinone oxidoreductases.
    Cecchini G; Maklashina E; Yankovskaya V; Iverson TM; Iwata S
    FEBS Lett; 2003 Jun; 545(1):31-8. PubMed ID: 12788489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity of the quinone-binding site of the complex II homolog quinol:fumarate reductase.
    Singh PK; Sarwar M; Maklashina E; Kotlyar V; Rajagukguk S; Tomasiak TM; Cecchini G; Iverson TM
    J Biol Chem; 2013 Aug; 288(34):24293-301. PubMed ID: 23836905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumarate reductase and succinate oxidase activity of Escherichia coli complex II homologs are perturbed differently by mutation of the flavin binding domain.
    Maklashina E; Iverson TM; Sher Y; Kotlyar V; Andréll J; Mirza O; Hudson JM; Armstrong FA; Rothery RA; Weiner JH; Cecchini G
    J Biol Chem; 2006 Apr; 281(16):11357-65. PubMed ID: 16484232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative sites for proton entry from the cytoplasm to the quinone binding site in Escherichia coli succinate dehydrogenase.
    Cheng VW; Johnson A; Rothery RA; Weiner JH
    Biochemistry; 2008 Sep; 47(35):9107-16. PubMed ID: 18690748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b.
    Tran QM; Rothery RA; Maklashina E; Cecchini G; Weiner JH
    J Biol Chem; 2006 Oct; 281(43):32310-7. PubMed ID: 16950775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the quinone reduction in the bc1 complex: a comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site.
    Gao X; Wen X; Esser L; Quinn B; Yu L; Yu CA; Xia D
    Biochemistry; 2003 Aug; 42(30):9067-80. PubMed ID: 12885240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spin labeling of the Escherichia coli NADH ubiquinone oxidoreductase (complex I).
    Pohl T; Spatzal T; Aksoyoglu M; Schleicher E; Rostas AM; Lay H; Glessner U; Boudon C; Hellwig P; Weber S; Friedrich T
    Biochim Biophys Acta; 2010 Dec; 1797(12):1894-900. PubMed ID: 20959113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in protonation of ubiquinone and menaquinone in fumarate reductase from Escherichia coli.
    Maklashina E; Hellwig P; Rothery RA; Kotlyar V; Sher Y; Weiner JH; Cecchini G
    J Biol Chem; 2006 Sep; 281(36):26655-64. PubMed ID: 16829675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a direction: electron transfer and catalysis in Escherichia coli complex II enzymes.
    Maklashina E; Cecchini G; Dikanov SA
    Biochim Biophys Acta; 2013 May; 1827(5):668-78. PubMed ID: 23396003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and experimental insight into the molecular mechanism of carboxamide inhibitors of succinate-ubquinone oxidoreductase.
    Zhu XL; Xiong L; Li H; Song XY; Liu JJ; Yang GF
    ChemMedChem; 2014 Jul; 9(7):1512-21. PubMed ID: 24678033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.